[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2021 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 59.23%
YoY- 13.78%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 1,803,215 1,729,188 1,723,276 1,970,622 1,465,684 1,387,998 1,200,652 7.00%
PBT 42,378 15,535 41,960 53,768 45,206 42,724 40,677 0.68%
Tax -12,353 -10,445 -12,190 -17,052 -13,184 -13,814 -17,322 -5.47%
NP 30,025 5,090 29,770 36,716 32,022 28,910 23,355 4.27%
-
NP to SH 28,443 4,608 28,456 36,840 32,378 28,898 22,980 3.61%
-
Tax Rate 29.15% 67.24% 29.05% 31.71% 29.16% 32.33% 42.58% -
Total Cost 1,773,190 1,724,098 1,693,506 1,933,906 1,433,662 1,359,088 1,177,297 7.05%
-
Net Worth -272,968 -137,571 406,087 357,275 357,891 518,564 519,642 -
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div - - 17,029 30,100 22,204 22,149 23,383 -
Div Payout % - - 59.84% 81.71% 68.58% 76.65% 101.76% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth -272,968 -137,571 406,087 357,275 357,891 518,564 519,642 -
NOSH 1,441,229 1,310,208 1,309,126 261,991 261,705 261,229 259,821 33.01%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 1.67% 0.29% 1.73% 1.86% 2.18% 2.08% 1.95% -
ROE 0.00% 0.00% 7.01% 10.31% 9.05% 5.57% 4.42% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 125.12 131.98 131.55 150.58 561.06 532.65 462.11 -19.55%
EPS 1.97 0.35 2.17 2.82 12.39 11.09 8.84 -22.11%
DPS 0.00 0.00 1.30 2.30 8.50 8.50 9.00 -
NAPS -0.1894 -0.105 0.31 0.273 1.37 1.99 2.00 -
Adjusted Per Share Value based on latest NOSH - 261,991
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 125.11 119.98 119.57 136.73 101.69 96.30 83.31 7.00%
EPS 1.97 0.32 1.97 2.56 2.25 2.01 1.59 3.63%
DPS 0.00 0.00 1.18 2.09 1.54 1.54 1.62 -
NAPS -0.1894 -0.0955 0.2818 0.2479 0.2483 0.3598 0.3605 -
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 0.37 0.37 0.595 5.29 2.22 2.84 2.88 -
P/RPS 0.30 0.28 0.45 3.51 0.40 0.53 0.62 -11.38%
P/EPS 18.75 105.20 27.39 187.92 17.91 25.61 32.56 -8.78%
EY 5.33 0.95 3.65 0.53 5.58 3.90 3.07 9.62%
DY 0.00 0.00 2.18 0.43 3.83 2.99 3.13 -
P/NAPS 0.00 0.00 1.92 19.38 1.62 1.43 1.44 -
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 21/08/24 11/08/23 19/08/22 20/08/21 19/08/20 23/08/19 17/08/18 -
Price 0.43 0.42 0.595 0.925 4.42 2.66 3.11 -
P/RPS 0.34 0.32 0.45 0.61 0.79 0.50 0.67 -10.68%
P/EPS 21.79 119.42 27.39 32.86 35.66 23.99 35.16 -7.65%
EY 4.59 0.84 3.65 3.04 2.80 4.17 2.84 8.32%
DY 0.00 0.00 2.18 2.49 1.92 3.20 2.89 -
P/NAPS 0.00 0.00 1.92 3.39 3.23 1.34 1.56 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment